HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2018 | $1.51 K |
2019 | $17.8 K |
Total: | $19.3 K |
Period | Weight, tons. |
---|---|
2018 | 0.001 |
2019 | 0.4 |
Total: | 0.401 |
Group product | 2018 | 2019 | Ch. | ∑ (2018-2019) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $1.51 K | $17.8 K | 1075% | $19.3 K | 100% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | --- | --- | --- | --- | 0% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $1.51 K | $17.8 K | $19.3 K |
№ | Country | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | Germany | $44.6 M | 15.5% |
2 | Italy | $36.6 M | 12.8% |
3 | United States | $29 M | 10.1% |
4 | Spain | $25.8 M | 9% |
5 | Finland | $25.6 M | 8.9% |
6 | Japan | $19.5 M | 6.8% |
7 | Belarus | $19.5 M | 6.8% |
8 | Bulgaria | $18.3 M | 6.4% |
9 | Switzerland | $10.8 M | 3.8% |
10 | France | $9.7 M | 3.4% |
11 | United Kingdom | $9.2 M | 3.2% |
12 | China | $7.5 M | 2.6% |
13 | Slovenia | $7.2 M | 2.5% |
14 | South Korea | $4.1 M | 1.4% |
15 | Kazakhstan | $3.2 M | 1.1% |
... | ... | ... | ... |
38 | South Africa | $23.6 K | 0% |
39 | Thailand | $20.1 K | 0% |
40 | Lithuania | $19.3 K | 0% |
41 | Taiwan | $12.7 K | 0% |
42 | Cambodia | $10.4 K | 0% |
... | ... | ... | ... |
The total for all countries: | $287 M | 100% |
№ | Region | ∑ (2018-2019) | Ratio |
---|---|---|---|
1 | Moskva | $17.3 M | 97.4% |
2 | Nijegorodskaya oblast | $431 K | 2.4% |
3 | Sankt-Peterburg | $19.3 K | 0.1% |
4 | Kaliningradskaya oblast | $3.03 K | 0% |
5 | Moskovskaya oblast | $662 | 0% |
By all regions: | $17.7 M | 100% |